VANCOUVER, BC / ACCESSWIRE / September 26, 2019 / Apteryx Imaging Inc. ("Apteryx" or the "Company"), formerly LED Medical Diagnostics Inc. (TSXV:XRAY), has announced an update to their stock ticker for the Frankfurt Stock Exchange Open Market. Effective today, Apteryx Imaging has updated its ticker from LME to XRAY for the Frankfurt Stock Exchange Open Market, following previous updates to the Company's stock tickers for the TSX Venture Exchange (XRAY) and OTCQB market (APTEF). These moves are in conjunction with the previously announced corporate name change from LED Medical Diagnostics Inc. to Apteryx Imaging Inc.
For more information on Apteryx Imaging, please visit www.apteryx.com or call 877-APTERYX.
About Apteryx Imaging Inc.
Apteryx Imaging has provided dentists and oral health specialists with advanced diagnostic imaging software and device technologies for over 20 years. Our proprietary technologies include XrayVision, XVWeb and XrayVision DCV imaging software solutions, the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors.
Backed by an experienced leadership team and dedicated to a higher level of service and support, Apteryx Imaging is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSXV under the symbol XRAY, the OTCQB under the symbol APTEF, as well as the Frankfurt Stock Exchange under the symbol XRAY.
Media Contact:
Apteryx Imaging
Chris Koch
Phone: 678.293.9413
Email: [email protected]
Corporate Contact:
Apteryx Imaging
David Gane, CEO
Phone: 604.434.4614 ext 227
Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Apteryx Imaging Inc.